nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC3—Fluorouracil—head and neck cancer	0.138	0.198	CbGbCtD
Lamivudine—ABCC4—Fluorouracil—head and neck cancer	0.105	0.151	CbGbCtD
Lamivudine—ABCC1—Vinblastine—head and neck cancer	0.0785	0.112	CbGbCtD
Lamivudine—SLC22A2—Vinblastine—head and neck cancer	0.0712	0.102	CbGbCtD
Lamivudine—ABCC1—Docetaxel—head and neck cancer	0.0647	0.0927	CbGbCtD
Lamivudine—ABCC2—Vinblastine—head and neck cancer	0.0581	0.0832	CbGbCtD
Lamivudine—ABCG2—Fluorouracil—head and neck cancer	0.0567	0.0812	CbGbCtD
Lamivudine—ABCC2—Docetaxel—head and neck cancer	0.0479	0.0686	CbGbCtD
Lamivudine—ABCG2—Docetaxel—head and neck cancer	0.0433	0.062	CbGbCtD
Lamivudine—ABCB1—Vinblastine—head and neck cancer	0.0189	0.0271	CbGbCtD
Lamivudine—ABCB1—Docetaxel—head and neck cancer	0.0156	0.0224	CbGbCtD
Lamivudine—Nail pigmentation—Hydroxyurea—head and neck cancer	0.0131	0.124	CcSEcCtD
Lamivudine—CMPK1—hair follicle—head and neck cancer	0.0037	0.0526	CbGeAlD
Lamivudine—PGK1—connective tissue—head and neck cancer	0.00349	0.0496	CbGeAlD
Lamivudine—Gemcitabine—TYMS—head and neck cancer	0.00304	1	CrCbGaD
Lamivudine—NME1—mouth—head and neck cancer	0.00302	0.0429	CbGeAlD
Lamivudine—PCYT1A—connective tissue—head and neck cancer	0.00276	0.0393	CbGeAlD
Lamivudine—NME1—neck—head and neck cancer	0.00258	0.0366	CbGeAlD
Lamivudine—PCYT2—head—head and neck cancer	0.00239	0.034	CbGeAlD
Lamivudine—NT5C—lymphoid tissue—head and neck cancer	0.00215	0.0306	CbGeAlD
Lamivudine—PGK1—head—head and neck cancer	0.00205	0.0292	CbGeAlD
Lamivudine—NT5C—thyroid gland—head and neck cancer	0.00196	0.0278	CbGeAlD
Lamivudine—NME1-NME2—head—head and neck cancer	0.00187	0.0266	CbGeAlD
Lamivudine—NME1—connective tissue—head and neck cancer	0.00185	0.0263	CbGeAlD
Lamivudine—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00183	0.0173	CcSEcCtD
Lamivudine—CMPK1—connective tissue—head and neck cancer	0.00178	0.0253	CbGeAlD
Lamivudine—SLC22A3—tongue—head and neck cancer	0.00175	0.0249	CbGeAlD
Lamivudine—NT5C—head—head and neck cancer	0.00173	0.0247	CbGeAlD
Lamivudine—Cardiomyopathy—Fluorouracil—head and neck cancer	0.00173	0.0165	CcSEcCtD
Lamivudine—NME2—epithelium—head and neck cancer	0.00165	0.0235	CbGeAlD
Lamivudine—PCYT1A—head—head and neck cancer	0.00163	0.0231	CbGeAlD
Lamivudine—Rectal haemorrhage—Vinblastine—head and neck cancer	0.0015	0.0142	CcSEcCtD
Lamivudine—Raised liver function tests—Docetaxel—head and neck cancer	0.00139	0.0132	CcSEcCtD
Lamivudine—NME1—lymphoid tissue—head and neck cancer	0.00135	0.0192	CbGeAlD
Lamivudine—NME1-NME2—lymph node—head and neck cancer	0.00131	0.0186	CbGeAlD
Lamivudine—CMPK1—lymphoid tissue—head and neck cancer	0.0013	0.0185	CbGeAlD
Lamivudine—NME2—lymphoid tissue—head and neck cancer	0.00127	0.0181	CbGeAlD
Lamivudine—Photophobia—Vinblastine—head and neck cancer	0.00127	0.012	CcSEcCtD
Lamivudine—ABCC1—hair follicle—head and neck cancer	0.00124	0.0177	CbGeAlD
Lamivudine—NME1—thyroid gland—head and neck cancer	0.00123	0.0174	CbGeAlD
Lamivudine—NT5C—lymph node—head and neck cancer	0.00121	0.0173	CbGeAlD
Lamivudine—CMPK1—thyroid gland—head and neck cancer	0.00118	0.0168	CbGeAlD
Lamivudine—SLC22A3—mouth—head and neck cancer	0.00118	0.0168	CbGeAlD
Lamivudine—NME2—thyroid gland—head and neck cancer	0.00116	0.0164	CbGeAlD
Lamivudine—Phlebitis—Vinblastine—head and neck cancer	0.00114	0.0108	CcSEcCtD
Lamivudine—Deafness—Vinblastine—head and neck cancer	0.0011	0.0104	CcSEcCtD
Lamivudine—NME1—head—head and neck cancer	0.00109	0.0155	CbGeAlD
Lamivudine—CMPK1—head—head and neck cancer	0.00105	0.0149	CbGeAlD
Lamivudine—NME2—head—head and neck cancer	0.00103	0.0146	CbGeAlD
Lamivudine—DCK—parotid gland—head and neck cancer	0.00101	0.0143	CbGeAlD
Lamivudine—DCK—saliva-secreting gland—head and neck cancer	0.000965	0.0137	CbGeAlD
Lamivudine—Inflammation—Fluorouracil—head and neck cancer	0.000915	0.00869	CcSEcCtD
Lamivudine—Throat sore—Docetaxel—head and neck cancer	0.000888	0.00844	CcSEcCtD
Lamivudine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00088	0.00836	CcSEcCtD
Lamivudine—Photophobia—Fluorouracil—head and neck cancer	0.000833	0.00791	CcSEcCtD
Lamivudine—SLC22A3—parotid gland—head and neck cancer	0.000821	0.0117	CbGeAlD
Lamivudine—Pancytopenia—Vinblastine—head and neck cancer	0.000805	0.00765	CcSEcCtD
Lamivudine—Rhinorrhoea—Docetaxel—head and neck cancer	0.00079	0.00751	CcSEcCtD
Lamivudine—SLC22A3—saliva-secreting gland—head and neck cancer	0.000786	0.0112	CbGeAlD
Lamivudine—Sepsis—Fluorouracil—head and neck cancer	0.00077	0.00731	CcSEcCtD
Lamivudine—NME1—lymph node—head and neck cancer	0.000762	0.0108	CbGeAlD
Lamivudine—Pancreatitis—Hydroxyurea—head and neck cancer	0.000758	0.0072	CcSEcCtD
Lamivudine—Depression—Vinblastine—head and neck cancer	0.000754	0.00716	CcSEcCtD
Lamivudine—DCK—trachea—head and neck cancer	0.000744	0.0106	CbGeAlD
Lamivudine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000741	0.00704	CcSEcCtD
Lamivudine—CMPK1—lymph node—head and neck cancer	0.000735	0.0104	CbGeAlD
Lamivudine—Pancytopenia—Hydroxyurea—head and neck cancer	0.000734	0.00697	CcSEcCtD
Lamivudine—Dysuria—Hydroxyurea—head and neck cancer	0.000723	0.00687	CcSEcCtD
Lamivudine—Neutropenia—Hydroxyurea—head and neck cancer	0.000723	0.00687	CcSEcCtD
Lamivudine—SLC22A3—connective tissue—head and neck cancer	0.000723	0.0103	CbGeAlD
Lamivudine—NME2—lymph node—head and neck cancer	0.000718	0.0102	CbGeAlD
Lamivudine—Bone disorder—Docetaxel—head and neck cancer	0.000709	0.00673	CcSEcCtD
Lamivudine—Agranulocytosis—Vinblastine—head and neck cancer	0.000705	0.0067	CcSEcCtD
Lamivudine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000704	0.00669	CcSEcCtD
Lamivudine—Drug interaction—Docetaxel—head and neck cancer	0.00069	0.00655	CcSEcCtD
Lamivudine—ABCC1—parotid gland—head and neck cancer	0.000679	0.00965	CbGeAlD
Lamivudine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000676	0.00642	CcSEcCtD
Lamivudine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000675	0.00641	CcSEcCtD
Lamivudine—Pharyngitis—Vinblastine—head and neck cancer	0.000674	0.0064	CcSEcCtD
Lamivudine—Hearing impaired—Docetaxel—head and neck cancer	0.000673	0.00639	CcSEcCtD
Lamivudine—Stomatitis—Hydroxyurea—head and neck cancer	0.000672	0.00638	CcSEcCtD
Lamivudine—Inflammation—Docetaxel—head and neck cancer	0.00066	0.00627	CcSEcCtD
Lamivudine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000652	0.00619	CcSEcCtD
Lamivudine—DCK—lymphoid tissue—head and neck cancer	0.000648	0.00922	CbGeAlD
Lamivudine—Neuropathy—Docetaxel—head and neck cancer	0.000601	0.00571	CcSEcCtD
Lamivudine—Alopecia—Vinblastine—head and neck cancer	0.0006	0.0057	CcSEcCtD
Lamivudine—DCK—thyroid gland—head and neck cancer	0.000589	0.00837	CbGeAlD
Lamivudine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000576	0.00547	CcSEcCtD
Lamivudine—Muscular weakness—Fluorouracil—head and neck cancer	0.000568	0.00539	CcSEcCtD
Lamivudine—ABCC3—thyroid gland—head and neck cancer	0.000564	0.00801	CbGeAlD
Lamivudine—ABCG2—parotid gland—head and neck cancer	0.000562	0.00799	CbGeAlD
Lamivudine—Dysphagia—Fluorouracil—head and neck cancer	0.000557	0.00529	CcSEcCtD
Lamivudine—Sepsis—Docetaxel—head and neck cancer	0.000556	0.00528	CcSEcCtD
Lamivudine—Chills—Hydroxyurea—head and neck cancer	0.000555	0.00527	CcSEcCtD
Lamivudine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000548	0.00521	CcSEcCtD
Lamivudine—Alopecia—Hydroxyurea—head and neck cancer	0.000547	0.00519	CcSEcCtD
Lamivudine—Anaemia—Vinblastine—head and neck cancer	0.000546	0.00519	CcSEcCtD
Lamivudine—Phlebitis—Docetaxel—head and neck cancer	0.000539	0.00512	CcSEcCtD
Lamivudine—Erythema—Hydroxyurea—head and neck cancer	0.000539	0.00512	CcSEcCtD
Lamivudine—ABCG2—saliva-secreting gland—head and neck cancer	0.000538	0.00765	CbGeAlD
Lamivudine—Malaise—Vinblastine—head and neck cancer	0.000533	0.00506	CcSEcCtD
Lamivudine—Vertigo—Vinblastine—head and neck cancer	0.000531	0.00504	CcSEcCtD
Lamivudine—Leukopenia—Vinblastine—head and neck cancer	0.000529	0.00502	CcSEcCtD
Lamivudine—Pancytopenia—Fluorouracil—head and neck cancer	0.000529	0.00502	CcSEcCtD
Lamivudine—DCK—head—head and neck cancer	0.000522	0.00743	CbGeAlD
Lamivudine—Deafness—Docetaxel—head and neck cancer	0.00052	0.00493	CcSEcCtD
Lamivudine—Convulsion—Vinblastine—head and neck cancer	0.000512	0.00486	CcSEcCtD
Lamivudine—ABCC1—trachea—head and neck cancer	0.000502	0.00713	CbGeAlD
Lamivudine—ABCC3—head—head and neck cancer	0.0005	0.00711	CbGeAlD
Lamivudine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0005	0.00475	CcSEcCtD
Lamivudine—Anaemia—Hydroxyurea—head and neck cancer	0.000498	0.00473	CcSEcCtD
Lamivudine—Discomfort—Vinblastine—head and neck cancer	0.000497	0.00472	CcSEcCtD
Lamivudine—Renal impairment—Docetaxel—head and neck cancer	0.000488	0.00464	CcSEcCtD
Lamivudine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000486	0.00462	CcSEcCtD
Lamivudine—Malaise—Hydroxyurea—head and neck cancer	0.000486	0.00461	CcSEcCtD
Lamivudine—Stomatitis—Fluorouracil—head and neck cancer	0.000484	0.00459	CcSEcCtD
Lamivudine—Leukopenia—Hydroxyurea—head and neck cancer	0.000482	0.00458	CcSEcCtD
Lamivudine—SLC22A3—thyroid gland—head and neck cancer	0.00048	0.00682	CbGeAlD
Lamivudine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000472	0.00448	CcSEcCtD
Lamivudine—Epistaxis—Fluorouracil—head and neck cancer	0.000468	0.00445	CcSEcCtD
Lamivudine—Convulsion—Hydroxyurea—head and neck cancer	0.000467	0.00443	CcSEcCtD
Lamivudine—Sinusitis—Fluorouracil—head and neck cancer	0.000466	0.00442	CcSEcCtD
Lamivudine—ABCC4—thyroid gland—head and neck cancer	0.000465	0.00662	CbGeAlD
Lamivudine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000463	0.0044	CcSEcCtD
Lamivudine—Anorexia—Vinblastine—head and neck cancer	0.00046	0.00436	CcSEcCtD
Lamivudine—Migraine—Docetaxel—head and neck cancer	0.000457	0.00434	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000456	0.00433	CcSEcCtD
Lamivudine—Discomfort—Hydroxyurea—head and neck cancer	0.000453	0.0043	CcSEcCtD
Lamivudine—Rhinitis—Fluorouracil—head and neck cancer	0.000447	0.00424	CcSEcCtD
Lamivudine—SLC22A1—head—head and neck cancer	0.000445	0.00633	CbGeAlD
Lamivudine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000443	0.00421	CcSEcCtD
Lamivudine—Pharyngitis—Fluorouracil—head and neck cancer	0.000442	0.0042	CcSEcCtD
Lamivudine—Oedema—Hydroxyurea—head and neck cancer	0.00044	0.00418	CcSEcCtD
Lamivudine—Infection—Hydroxyurea—head and neck cancer	0.000437	0.00415	CcSEcCtD
Lamivudine—Paraesthesia—Vinblastine—head and neck cancer	0.000433	0.00411	CcSEcCtD
Lamivudine—Dehydration—Docetaxel—head and neck cancer	0.000432	0.0041	CcSEcCtD
Lamivudine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000431	0.0041	CcSEcCtD
Lamivudine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000431	0.00409	CcSEcCtD
Lamivudine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000429	0.00408	CcSEcCtD
Lamivudine—Skin disorder—Hydroxyurea—head and neck cancer	0.000427	0.00406	CcSEcCtD
Lamivudine—SLC22A3—head—head and neck cancer	0.000426	0.00605	CbGeAlD
Lamivudine—Abdominal pain upper—Docetaxel—head and neck cancer	0.000424	0.00403	CcSEcCtD
Lamivudine—Anorexia—Hydroxyurea—head and neck cancer	0.000419	0.00398	CcSEcCtD
Lamivudine—Decreased appetite—Vinblastine—head and neck cancer	0.000419	0.00398	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000419	0.00397	CcSEcCtD
Lamivudine—Cramp muscle—Docetaxel—head and neck cancer	0.000419	0.00397	CcSEcCtD
Lamivudine—Nasopharyngitis—Docetaxel—head and neck cancer	0.000416	0.00395	CcSEcCtD
Lamivudine—ABCC4—head—head and neck cancer	0.000413	0.00587	CbGeAlD
Lamivudine—Pain—Vinblastine—head and neck cancer	0.000412	0.00392	CcSEcCtD
Lamivudine—Constipation—Vinblastine—head and neck cancer	0.000412	0.00392	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00041	0.00389	CcSEcCtD
Lamivudine—Dysphagia—Docetaxel—head and neck cancer	0.000402	0.00381	CcSEcCtD
Lamivudine—Feeling abnormal—Vinblastine—head and neck cancer	0.000397	0.00377	CcSEcCtD
Lamivudine—ABCC1—thyroid gland—head and neck cancer	0.000397	0.00564	CbGeAlD
Lamivudine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000394	0.00374	CcSEcCtD
Lamivudine—Alopecia—Fluorouracil—head and neck cancer	0.000394	0.00374	CcSEcCtD
Lamivudine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000392	0.00372	CcSEcCtD
Lamivudine—Somnolence—Hydroxyurea—head and neck cancer	0.000391	0.00371	CcSEcCtD
Lamivudine—Erythema—Fluorouracil—head and neck cancer	0.000388	0.00368	CcSEcCtD
Lamivudine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000387	0.00368	CcSEcCtD
Lamivudine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000382	0.00363	CcSEcCtD
Lamivudine—Pancytopenia—Docetaxel—head and neck cancer	0.000381	0.00362	CcSEcCtD
Lamivudine—Abdominal pain—Vinblastine—head and neck cancer	0.000381	0.00362	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00038	0.00361	CcSEcCtD
Lamivudine—Fatigue—Hydroxyurea—head and neck cancer	0.000379	0.0036	CcSEcCtD
Lamivudine—Pain—Hydroxyurea—head and neck cancer	0.000376	0.00357	CcSEcCtD
Lamivudine—Constipation—Hydroxyurea—head and neck cancer	0.000376	0.00357	CcSEcCtD
Lamivudine—Neutropenia—Docetaxel—head and neck cancer	0.000376	0.00357	CcSEcCtD
Lamivudine—DCK—lymph node—head and neck cancer	0.000366	0.0052	CbGeAlD
Lamivudine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000362	0.00344	CcSEcCtD
Lamivudine—Anaemia—Fluorouracil—head and neck cancer	0.000358	0.0034	CcSEcCtD
Lamivudine—Hypersensitivity—Vinblastine—head and neck cancer	0.000355	0.00337	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000355	0.00337	CcSEcCtD
Lamivudine—Renal failure—Docetaxel—head and neck cancer	0.000352	0.00334	CcSEcCtD
Lamivudine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000351	0.00333	CcSEcCtD
Lamivudine—ABCC3—lymph node—head and neck cancer	0.00035	0.00498	CbGeAlD
Lamivudine—Stomatitis—Docetaxel—head and neck cancer	0.000349	0.00332	CcSEcCtD
Lamivudine—Jaundice—Docetaxel—head and neck cancer	0.000349	0.00332	CcSEcCtD
Lamivudine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000348	0.0033	CcSEcCtD
Lamivudine—Leukopenia—Fluorouracil—head and neck cancer	0.000347	0.0033	CcSEcCtD
Lamivudine—Asthenia—Vinblastine—head and neck cancer	0.000346	0.00329	CcSEcCtD
Lamivudine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000339	0.00322	CcSEcCtD
Lamivudine—Epistaxis—Docetaxel—head and neck cancer	0.000338	0.00321	CcSEcCtD
Lamivudine—Convulsion—Fluorouracil—head and neck cancer	0.000336	0.00319	CcSEcCtD
Lamivudine—Agranulocytosis—Docetaxel—head and neck cancer	0.000334	0.00317	CcSEcCtD
Lamivudine—Chest pain—Fluorouracil—head and neck cancer	0.00033	0.00314	CcSEcCtD
Lamivudine—Myalgia—Fluorouracil—head and neck cancer	0.00033	0.00314	CcSEcCtD
Lamivudine—Diarrhoea—Vinblastine—head and neck cancer	0.00033	0.00313	CcSEcCtD
Lamivudine—ABCG2—thyroid gland—head and neck cancer	0.000328	0.00467	CbGeAlD
Lamivudine—Discomfort—Fluorouracil—head and neck cancer	0.000326	0.0031	CcSEcCtD
Lamivudine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000324	0.00308	CcSEcCtD
Lamivudine—Rhinitis—Docetaxel—head and neck cancer	0.000322	0.00306	CcSEcCtD
Lamivudine—Hepatitis—Docetaxel—head and neck cancer	0.000322	0.00305	CcSEcCtD
Lamivudine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00032	0.00304	CcSEcCtD
Lamivudine—Confusional state—Fluorouracil—head and neck cancer	0.000319	0.00303	CcSEcCtD
Lamivudine—Pharyngitis—Docetaxel—head and neck cancer	0.000319	0.00303	CcSEcCtD
Lamivudine—Dizziness—Vinblastine—head and neck cancer	0.000319	0.00303	CcSEcCtD
Lamivudine—Oedema—Fluorouracil—head and neck cancer	0.000316	0.00301	CcSEcCtD
Lamivudine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000316	0.00301	CcSEcCtD
Lamivudine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000316	0.003	CcSEcCtD
Lamivudine—Asthenia—Hydroxyurea—head and neck cancer	0.000315	0.003	CcSEcCtD
Lamivudine—Infection—Fluorouracil—head and neck cancer	0.000314	0.00299	CcSEcCtD
Lamivudine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00031	0.00295	CcSEcCtD
Lamivudine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00031	0.00294	CcSEcCtD
Lamivudine—Vomiting—Vinblastine—head and neck cancer	0.000307	0.00291	CcSEcCtD
Lamivudine—Erythema multiforme—Docetaxel—head and neck cancer	0.000304	0.00289	CcSEcCtD
Lamivudine—Headache—Vinblastine—head and neck cancer	0.000302	0.00287	CcSEcCtD
Lamivudine—Anorexia—Fluorouracil—head and neck cancer	0.000302	0.00287	CcSEcCtD
Lamivudine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000301	0.00286	CcSEcCtD
Lamivudine—SLC22A3—lymph node—head and neck cancer	0.000298	0.00424	CbGeAlD
Lamivudine—Hypotension—Fluorouracil—head and neck cancer	0.000296	0.00281	CcSEcCtD
Lamivudine—Dizziness—Hydroxyurea—head and neck cancer	0.000291	0.00276	CcSEcCtD
Lamivudine—Immune system disorder—Docetaxel—head and neck cancer	0.00029	0.00276	CcSEcCtD
Lamivudine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00029	0.00275	CcSEcCtD
Lamivudine—ABCC4—lymph node—head and neck cancer	0.000289	0.00411	CbGeAlD
Lamivudine—Chills—Docetaxel—head and neck cancer	0.000288	0.00274	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000288	0.00274	CcSEcCtD
Lamivudine—Nausea—Vinblastine—head and neck cancer	0.000286	0.00272	CcSEcCtD
Lamivudine—Insomnia—Fluorouracil—head and neck cancer	0.000286	0.00272	CcSEcCtD
Lamivudine—Paraesthesia—Fluorouracil—head and neck cancer	0.000284	0.0027	CcSEcCtD
Lamivudine—Alopecia—Docetaxel—head and neck cancer	0.000284	0.0027	CcSEcCtD
Lamivudine—Dyspnoea—Fluorouracil—head and neck cancer	0.000282	0.00268	CcSEcCtD
Lamivudine—Somnolence—Fluorouracil—head and neck cancer	0.000281	0.00267	CcSEcCtD
Lamivudine—Malnutrition—Docetaxel—head and neck cancer	0.00028	0.00266	CcSEcCtD
Lamivudine—Erythema—Docetaxel—head and neck cancer	0.00028	0.00266	CcSEcCtD
Lamivudine—ABCC2—lymph node—head and neck cancer	0.00028	0.00398	CbGeAlD
Lamivudine—Vomiting—Hydroxyurea—head and neck cancer	0.00028	0.00265	CcSEcCtD
Lamivudine—Dyspepsia—Fluorouracil—head and neck cancer	0.000279	0.00265	CcSEcCtD
Lamivudine—Rash—Hydroxyurea—head and neck cancer	0.000277	0.00263	CcSEcCtD
Lamivudine—Dermatitis—Hydroxyurea—head and neck cancer	0.000277	0.00263	CcSEcCtD
Lamivudine—Headache—Hydroxyurea—head and neck cancer	0.000275	0.00262	CcSEcCtD
Lamivudine—Decreased appetite—Fluorouracil—head and neck cancer	0.000275	0.00261	CcSEcCtD
Lamivudine—Dysgeusia—Docetaxel—head and neck cancer	0.000274	0.0026	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000273	0.00259	CcSEcCtD
Lamivudine—Back pain—Docetaxel—head and neck cancer	0.000271	0.00257	CcSEcCtD
Lamivudine—Pain—Fluorouracil—head and neck cancer	0.000271	0.00257	CcSEcCtD
Lamivudine—Muscle spasms—Docetaxel—head and neck cancer	0.000269	0.00256	CcSEcCtD
Lamivudine—Nausea—Hydroxyurea—head and neck cancer	0.000261	0.00248	CcSEcCtD
Lamivudine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000261	0.00248	CcSEcCtD
Lamivudine—Anaemia—Docetaxel—head and neck cancer	0.000259	0.00246	CcSEcCtD
Lamivudine—Urticaria—Fluorouracil—head and neck cancer	0.000251	0.00239	CcSEcCtD
Lamivudine—Syncope—Docetaxel—head and neck cancer	0.000251	0.00238	CcSEcCtD
Lamivudine—Leukopenia—Docetaxel—head and neck cancer	0.000251	0.00238	CcSEcCtD
Lamivudine—Body temperature increased—Fluorouracil—head and neck cancer	0.00025	0.00238	CcSEcCtD
Lamivudine—ABCC1—lymph node—head and neck cancer	0.000246	0.0035	CbGeAlD
Lamivudine—Loss of consciousness—Docetaxel—head and neck cancer	0.000246	0.00234	CcSEcCtD
Lamivudine—Cough—Docetaxel—head and neck cancer	0.000244	0.00232	CcSEcCtD
Lamivudine—Convulsion—Docetaxel—head and neck cancer	0.000243	0.0023	CcSEcCtD
Lamivudine—Arthralgia—Docetaxel—head and neck cancer	0.000238	0.00226	CcSEcCtD
Lamivudine—Chest pain—Docetaxel—head and neck cancer	0.000238	0.00226	CcSEcCtD
Lamivudine—Myalgia—Docetaxel—head and neck cancer	0.000238	0.00226	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000237	0.00225	CcSEcCtD
Lamivudine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000233	0.00221	CcSEcCtD
Lamivudine—Dry mouth—Docetaxel—head and neck cancer	0.000233	0.00221	CcSEcCtD
Lamivudine—ABCB1—epithelium—head and neck cancer	0.000232	0.00329	CbGeAlD
Lamivudine—Confusional state—Docetaxel—head and neck cancer	0.00023	0.00219	CcSEcCtD
Lamivudine—Oedema—Docetaxel—head and neck cancer	0.000228	0.00217	CcSEcCtD
Lamivudine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000228	0.00217	CcSEcCtD
Lamivudine—Infection—Docetaxel—head and neck cancer	0.000227	0.00216	CcSEcCtD
Lamivudine—Shock—Docetaxel—head and neck cancer	0.000225	0.00213	CcSEcCtD
Lamivudine—Nervous system disorder—Docetaxel—head and neck cancer	0.000224	0.00213	CcSEcCtD
Lamivudine—Pruritus—Fluorouracil—head and neck cancer	0.000224	0.00213	CcSEcCtD
Lamivudine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000224	0.00212	CcSEcCtD
Lamivudine—Skin disorder—Docetaxel—head and neck cancer	0.000222	0.00211	CcSEcCtD
Lamivudine—Anorexia—Docetaxel—head and neck cancer	0.000218	0.00207	CcSEcCtD
Lamivudine—Diarrhoea—Fluorouracil—head and neck cancer	0.000217	0.00206	CcSEcCtD
Lamivudine—Hypotension—Docetaxel—head and neck cancer	0.000213	0.00203	CcSEcCtD
Lamivudine—Dizziness—Fluorouracil—head and neck cancer	0.000209	0.00199	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000208	0.00198	CcSEcCtD
Lamivudine—Insomnia—Docetaxel—head and neck cancer	0.000207	0.00196	CcSEcCtD
Lamivudine—Paraesthesia—Docetaxel—head and neck cancer	0.000205	0.00195	CcSEcCtD
Lamivudine—ABCB1—trachea—head and neck cancer	0.000205	0.00291	CbGeAlD
Lamivudine—ABCG2—lymph node—head and neck cancer	0.000204	0.0029	CbGeAlD
Lamivudine—Dyspnoea—Docetaxel—head and neck cancer	0.000204	0.00193	CcSEcCtD
Lamivudine—Somnolence—Docetaxel—head and neck cancer	0.000203	0.00193	CcSEcCtD
Lamivudine—Vomiting—Fluorouracil—head and neck cancer	0.000201	0.00191	CcSEcCtD
Lamivudine—Dyspepsia—Docetaxel—head and neck cancer	0.000201	0.00191	CcSEcCtD
Lamivudine—Rash—Fluorouracil—head and neck cancer	0.0002	0.0019	CcSEcCtD
Lamivudine—Dermatitis—Fluorouracil—head and neck cancer	0.000199	0.00189	CcSEcCtD
Lamivudine—Decreased appetite—Docetaxel—head and neck cancer	0.000199	0.00189	CcSEcCtD
Lamivudine—Headache—Fluorouracil—head and neck cancer	0.000198	0.00188	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000197	0.00187	CcSEcCtD
Lamivudine—Fatigue—Docetaxel—head and neck cancer	0.000197	0.00187	CcSEcCtD
Lamivudine—Constipation—Docetaxel—head and neck cancer	0.000195	0.00186	CcSEcCtD
Lamivudine—Pain—Docetaxel—head and neck cancer	0.000195	0.00186	CcSEcCtD
Lamivudine—Feeling abnormal—Docetaxel—head and neck cancer	0.000188	0.00179	CcSEcCtD
Lamivudine—Nausea—Fluorouracil—head and neck cancer	0.000188	0.00179	CcSEcCtD
Lamivudine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000187	0.00177	CcSEcCtD
Lamivudine—Abdominal pain—Docetaxel—head and neck cancer	0.000181	0.00171	CcSEcCtD
Lamivudine—Body temperature increased—Docetaxel—head and neck cancer	0.000181	0.00171	CcSEcCtD
Lamivudine—ABCB1—lymphoid tissue—head and neck cancer	0.000178	0.00254	CbGeAlD
Lamivudine—Hypersensitivity—Docetaxel—head and neck cancer	0.000168	0.0016	CcSEcCtD
Lamivudine—Asthenia—Docetaxel—head and neck cancer	0.000164	0.00156	CcSEcCtD
Lamivudine—ABCB1—thyroid gland—head and neck cancer	0.000162	0.0023	CbGeAlD
Lamivudine—Pruritus—Docetaxel—head and neck cancer	0.000162	0.00153	CcSEcCtD
Lamivudine—ABCC2—NRF2 pathway—GSTM1—head and neck cancer	0.000161	0.00131	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00016	0.0013	CbGpPWpGaD
Lamivudine—Diarrhoea—Docetaxel—head and neck cancer	0.000156	0.00148	CcSEcCtD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000156	0.00127	CbGpPWpGaD
Lamivudine—NME1—Metabolism—NAT2—head and neck cancer	0.000155	0.00126	CbGpPWpGaD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000154	0.00125	CbGpPWpGaD
Lamivudine—Dizziness—Docetaxel—head and neck cancer	0.000151	0.00143	CcSEcCtD
Lamivudine—ABCC3—Metabolism—UROD—head and neck cancer	0.000148	0.0012	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—TYMS—head and neck cancer	0.000147	0.0012	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—TYMS—head and neck cancer	0.000147	0.0012	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—TYMS—head and neck cancer	0.000147	0.0012	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GSTM1—head and neck cancer	0.000145	0.00118	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GSTM1—head and neck cancer	0.000145	0.00118	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GSTM1—head and neck cancer	0.000145	0.00118	CbGpPWpGaD
Lamivudine—Vomiting—Docetaxel—head and neck cancer	0.000145	0.00138	CcSEcCtD
Lamivudine—Rash—Docetaxel—head and neck cancer	0.000144	0.00137	CcSEcCtD
Lamivudine—Dermatitis—Docetaxel—head and neck cancer	0.000144	0.00137	CcSEcCtD
Lamivudine—ABCB1—head—head and neck cancer	0.000144	0.00204	CbGeAlD
Lamivudine—Headache—Docetaxel—head and neck cancer	0.000143	0.00136	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000142	0.00116	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000139	0.00113	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GPX1—head and neck cancer	0.000139	0.00113	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GPX1—head and neck cancer	0.000139	0.00113	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GPX1—head and neck cancer	0.000139	0.00113	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—CYP1A1—head and neck cancer	0.000138	0.00112	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—CYP1A1—head and neck cancer	0.000138	0.00112	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CYP1A1—head and neck cancer	0.000138	0.00112	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000138	0.00112	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—VEGFA—head and neck cancer	0.000137	0.00111	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000136	0.00111	CbGpPWpGaD
Lamivudine—Nausea—Docetaxel—head and neck cancer	0.000136	0.00129	CcSEcCtD
Lamivudine—NME1—Metabolism—DPYD—head and neck cancer	0.000136	0.0011	CbGpPWpGaD
Lamivudine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.000135	0.0011	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000132	0.00107	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.00013	0.00106	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00013	0.00106	CbGpPWpGaD
Lamivudine—NME1—Metabolism—YAP1—head and neck cancer	0.000129	0.00105	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000122	0.000989	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—TYMS—head and neck cancer	0.00012	0.000974	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GSTM1—head and neck cancer	0.000118	0.000963	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000117	0.000952	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000116	0.000946	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—UROD—head and neck cancer	0.000116	0.000944	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000115	0.000935	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000115	0.000932	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GPX1—head and neck cancer	0.000113	0.000922	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000113	0.000922	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000113	0.00092	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000113	0.000917	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—CYP1A1—head and neck cancer	0.000112	0.000913	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—TYMS—head and neck cancer	0.000111	0.000906	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GSTM1—head and neck cancer	0.00011	0.000896	CbGpPWpGaD
Lamivudine—PGK1—Disease—NOTCH1—head and neck cancer	0.000107	0.000873	CbGpPWpGaD
Lamivudine—DCK—Metabolism—NAT2—head and neck cancer	0.000106	0.000862	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000106	0.000859	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GPX1—head and neck cancer	0.000105	0.000858	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CYP1A1—head and neck cancer	0.000104	0.000849	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000103	0.000835	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—UROD—head and neck cancer	0.000102	0.000831	CbGpPWpGaD
Lamivudine—NME2—Metabolism—TYMS—head and neck cancer	0.000102	0.000829	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—UROD—head and neck cancer	0.000101	0.000822	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GSTM1—head and neck cancer	0.000101	0.000819	CbGpPWpGaD
Lamivudine—ABCB1—lymph node—head and neck cancer	0.000101	0.00143	CbGeAlD
Lamivudine—NME2—Metabolism—GPX1—head and neck cancer	9.65e-05	0.000784	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CYP1A1—head and neck cancer	9.55e-05	0.000776	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—UROD—head and neck cancer	9.42e-05	0.000766	CbGpPWpGaD
Lamivudine—DCK—Metabolism—DPYD—head and neck cancer	9.3e-05	0.000756	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.01e-05	0.000732	CbGpPWpGaD
Lamivudine—DCK—Metabolism—YAP1—head and neck cancer	8.82e-05	0.000717	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.58e-05	0.000697	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	8.54e-05	0.000694	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTGS2—head and neck cancer	8.19e-05	0.000666	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTGS2—head and neck cancer	8.19e-05	0.000666	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTGS2—head and neck cancer	8.19e-05	0.000666	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTGS2—head and neck cancer	7.97e-05	0.000648	CbGpPWpGaD
Lamivudine—NME1—Metabolism—TYMS—head and neck cancer	7.72e-05	0.000628	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GSTM1—head and neck cancer	7.63e-05	0.000621	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.47e-05	0.000607	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GPX1—head and neck cancer	7.31e-05	0.000594	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CYP1A1—head and neck cancer	7.24e-05	0.000588	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTEN—head and neck cancer	7.14e-05	0.000581	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTEN—head and neck cancer	7.14e-05	0.000581	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTEN—head and neck cancer	7.14e-05	0.000581	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IL2—head and neck cancer	7.14e-05	0.000581	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTEN—head and neck cancer	6.95e-05	0.000566	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NAT2—head and neck cancer	6.69e-05	0.000544	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTGS2—head and neck cancer	6.68e-05	0.000543	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.53e-05	0.000531	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.47e-05	0.000526	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL2—head and neck cancer	6.45e-05	0.000524	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	6.33e-05	0.000515	CbGpPWpGaD
Lamivudine—PGK1—Disease—STAT3—head and neck cancer	6.22e-05	0.000506	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTGS2—head and neck cancer	6.21e-05	0.000505	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.2e-05	0.000504	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	6.16e-05	0.000501	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NAT2—head and neck cancer	6.15e-05	0.0005	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	6.07e-05	0.000494	CbGpPWpGaD
Lamivudine—PGK1—Disease—MAPK3—head and neck cancer	5.94e-05	0.000483	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—DPYD—head and neck cancer	5.87e-05	0.000477	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTEN—head and neck cancer	5.82e-05	0.000474	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	5.74e-05	0.000467	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTGS2—head and neck cancer	5.68e-05	0.000462	CbGpPWpGaD
Lamivudine—PGK1—Disease—MAPK1—head and neck cancer	5.65e-05	0.00046	CbGpPWpGaD
Lamivudine—PGK1—Disease—EGFR—head and neck cancer	5.65e-05	0.00046	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—YAP1—head and neck cancer	5.57e-05	0.000453	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—UROD—head and neck cancer	5.52e-05	0.000449	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	5.48e-05	0.000446	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	5.46e-05	0.000444	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTEN—head and neck cancer	5.41e-05	0.00044	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—DPYD—head and neck cancer	5.4e-05	0.000439	CbGpPWpGaD
Lamivudine—DCK—Metabolism—TYMS—head and neck cancer	5.3e-05	0.000431	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GSTM1—head and neck cancer	5.24e-05	0.000426	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.12e-05	0.000416	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—YAP1—head and neck cancer	5.12e-05	0.000416	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.07e-05	0.000412	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PIK3CA—head and neck cancer	5.04e-05	0.00041	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PIK3CA—head and neck cancer	5.04e-05	0.00041	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PIK3CA—head and neck cancer	5.04e-05	0.00041	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GPX1—head and neck cancer	5.01e-05	0.000408	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP1A1—head and neck cancer	4.96e-05	0.000404	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTEN—head and neck cancer	4.95e-05	0.000403	CbGpPWpGaD
Lamivudine—PGK1—Disease—PIK3CA—head and neck cancer	4.91e-05	0.000399	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NAT2—head and neck cancer	4.82e-05	0.000392	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	4.74e-05	0.000386	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—head and neck cancer	4.54e-05	0.000369	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—head and neck cancer	4.3e-05	0.00035	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4.3e-05	0.000349	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NAT2—head and neck cancer	4.24e-05	0.000345	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—DPYD—head and neck cancer	4.23e-05	0.000344	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.21e-05	0.000343	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NAT2—head and neck cancer	4.2e-05	0.000341	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—head and neck cancer	4.12e-05	0.000335	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—head and neck cancer	4.12e-05	0.000335	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—head and neck cancer	4.12e-05	0.000335	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—head and neck cancer	4.11e-05	0.000334	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.04e-05	0.000328	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—YAP1—head and neck cancer	4.01e-05	0.000326	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—head and neck cancer	4.01e-05	0.000326	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4e-05	0.000326	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NAT2—head and neck cancer	3.91e-05	0.000318	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.87e-05	0.000315	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.85e-05	0.000313	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—head and neck cancer	3.82e-05	0.000311	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTEN—head and neck cancer	3.75e-05	0.000305	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—DPYD—head and neck cancer	3.72e-05	0.000302	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—head and neck cancer	3.68e-05	0.000299	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—DPYD—head and neck cancer	3.68e-05	0.000299	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.62e-05	0.000294	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—YAP1—head and neck cancer	3.53e-05	0.000287	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—YAP1—head and neck cancer	3.49e-05	0.000284	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—head and neck cancer	3.49e-05	0.000284	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.45e-05	0.00028	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.43e-05	0.000279	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—DPYD—head and neck cancer	3.43e-05	0.000279	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—head and neck cancer	3.36e-05	0.000273	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.35e-05	0.000273	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TYMS—head and neck cancer	3.34e-05	0.000272	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTM1—head and neck cancer	3.31e-05	0.000269	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MAPK1—head and neck cancer	3.29e-05	0.000268	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—YAP1—head and neck cancer	3.26e-05	0.000265	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.21e-05	0.000261	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GPX1—head and neck cancer	3.17e-05	0.000257	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP1A1—head and neck cancer	3.13e-05	0.000255	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—head and neck cancer	3.13e-05	0.000254	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—head and neck cancer	3.12e-05	0.000254	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.1e-05	0.000252	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TYMS—head and neck cancer	3.07e-05	0.00025	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MAPK1—head and neck cancer	3.07e-05	0.000249	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—head and neck cancer	3.04e-05	0.000247	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.01e-05	0.000245	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.99e-05	0.000244	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK3—head and neck cancer	2.96e-05	0.000241	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—head and neck cancer	2.95e-05	0.00024	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GPX1—head and neck cancer	2.91e-05	0.000237	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1A1—head and neck cancer	2.88e-05	0.000234	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—head and neck cancer	2.85e-05	0.000232	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK1—head and neck cancer	2.82e-05	0.000229	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.71e-05	0.00022	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—head and neck cancer	2.65e-05	0.000215	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—head and neck cancer	2.64e-05	0.000215	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.63e-05	0.000214	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—head and neck cancer	2.57e-05	0.000209	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.56e-05	0.000208	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—head and neck cancer	2.46e-05	0.0002	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—head and neck cancer	2.44e-05	0.000199	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.43e-05	0.000198	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.43e-05	0.000198	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMS—head and neck cancer	2.41e-05	0.000196	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—head and neck cancer	2.38e-05	0.000194	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.37e-05	0.000192	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—head and neck cancer	2.36e-05	0.000192	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NAT2—head and neck cancer	2.29e-05	0.000187	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPX1—head and neck cancer	2.28e-05	0.000185	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—head and neck cancer	2.26e-05	0.000184	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—head and neck cancer	2.26e-05	0.000184	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—head and neck cancer	2.16e-05	0.000176	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOTCH1—head and neck cancer	2.16e-05	0.000176	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMS—head and neck cancer	2.12e-05	0.000172	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.11e-05	0.000172	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMS—head and neck cancer	2.1e-05	0.000171	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—head and neck cancer	2.1e-05	0.00017	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—head and neck cancer	2.07e-05	0.000169	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.04e-05	0.000166	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—DPYD—head and neck cancer	2.01e-05	0.000164	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPX1—head and neck cancer	2.01e-05	0.000163	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—head and neck cancer	2e-05	0.000162	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—head and neck cancer	1.99e-05	0.000162	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPX1—head and neck cancer	1.99e-05	0.000161	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—head and neck cancer	1.97e-05	0.00016	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMS—head and neck cancer	1.96e-05	0.000159	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—head and neck cancer	1.93e-05	0.000157	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—YAP1—head and neck cancer	1.91e-05	0.000155	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—head and neck cancer	1.86e-05	0.000152	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.85e-05	0.000151	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPX1—head and neck cancer	1.85e-05	0.000151	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—head and neck cancer	1.83e-05	0.000149	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—head and neck cancer	1.82e-05	0.000148	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.73e-05	0.00014	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—head and neck cancer	1.71e-05	0.000139	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—head and neck cancer	1.63e-05	0.000132	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—head and neck cancer	1.6e-05	0.00013	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—head and neck cancer	1.49e-05	0.000121	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—head and neck cancer	1.48e-05	0.000121	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—head and neck cancer	1.4e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—head and neck cancer	1.34e-05	0.000109	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—head and neck cancer	1.25e-05	0.000102	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—head and neck cancer	1.19e-05	9.71e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—head and neck cancer	1.18e-05	9.61e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—head and neck cancer	1.17e-05	9.52e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—head and neck cancer	1.17e-05	9.51e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—head and neck cancer	1.15e-05	9.32e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMS—head and neck cancer	1.15e-05	9.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK1—head and neck cancer	1.14e-05	9.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—head and neck cancer	1.14e-05	9.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—head and neck cancer	1.13e-05	9.21e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—head and neck cancer	1.09e-05	8.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX1—head and neck cancer	1.08e-05	8.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.07e-05	8.73e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—head and neck cancer	1.05e-05	8.57e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—head and neck cancer	1.03e-05	8.38e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—head and neck cancer	1.02e-05	8.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—head and neck cancer	9.86e-06	8.02e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—head and neck cancer	9.5e-06	7.73e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—head and neck cancer	9.37e-06	7.62e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—head and neck cancer	9.12e-06	7.42e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—head and neck cancer	8.61e-06	7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—head and neck cancer	8.26e-06	6.72e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—head and neck cancer	8.06e-06	6.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—head and neck cancer	7.27e-06	5.91e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—head and neck cancer	7.19e-06	5.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—head and neck cancer	6.75e-06	5.49e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—head and neck cancer	6.7e-06	5.45e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—head and neck cancer	6.39e-06	5.19e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—head and neck cancer	5.94e-06	4.83e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—head and neck cancer	5.88e-06	4.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—head and neck cancer	5.57e-06	4.53e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—head and neck cancer	5.48e-06	4.45e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—head and neck cancer	3.93e-06	3.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—head and neck cancer	3.21e-06	2.61e-05	CbGpPWpGaD
